Join
Live feed
·
PRReleasevia Quantisnow
MetaVia Inc. logo

MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035

ByQuantisnow·Wall Street's wire, on your screen.
MTVA· MetaVia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTVA (MetaVia Inc.) and more on Quantisnow.